The power of patient data & the future of health tech with Microsoft's Peter Lee and Dave deBronkart
This week on Second Opinion, we're sharing an episode from Peter Lee's Microsoft Research Podcast with guests Dave deBronkart and Christina Farr.
Making sense of healthcare deals, technology, policy, and the occasional industry curveball.
This week on Second Opinion, we're sharing an episode from Peter Lee's Microsoft Research Podcast with guests Dave deBronkart and Christina Farr.
Employers tell me that preventative health is harder than ever
This week on Second Opinion, Christina Farr and Ash Zenooz interview Seraphina Therapeutics CEO Steph Venn-Watson, unpacking why men dominate the longevity space, the cellular secrets of aging, and C15:0’s potential to boost health.
Their impact on hormone health may be just what women in this life phase need
Sometimes a little less money is the right outcome
When to raise, how much & from whom?
In this episode of Second Opinion, hosts Christina Farr, Ash Zenooz, and Luba Greenwood discuss the latest trends in healthcare, including conferences, the economic impact on health tech and biotech sectors, the potential for AI to reduce administrative burdens, and the dynamics of the IPO market.
And no, ChatGPT is not the answer
A Conversation with a Cardiologist from Heartbeat Health
Part 1 in our founder's guide to financing your women's health startup
A conversation with founder and cardiologist Dr. Jeff Wessler and his assessment on what separates longevity from prevention & public health